| scholarly article | Q13442814 |
| P50 | author | Ana C Coan | Q56893272 |
| Fernando Cendes | Q39615467 | ||
| P2860 | cites work | Epilepsy surgery outcomes in temporal lobe epilepsy with a normal MRI | Q24621849 |
| Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI) | Q26825591 | ||
| A randomized, controlled trial of surgery for temporal-lobe epilepsy | Q28210745 | ||
| Practice parameter: temporal lobe and localized neocortical resections for epilepsy | Q28211517 | ||
| Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy | Q28243859 | ||
| Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009 | Q28274778 | ||
| Surgery for seizures | Q28275323 | ||
| Mesial temporal lobe epilepsy: How do we improve surgical outcome? | Q30430410 | ||
| Patterns of altered functional connectivity in mesial temporal lobe epilepsy. | Q30544336 | ||
| Bilateral limbic diffusion abnormalities in unilateral temporal lobe epilepsy. | Q30977066 | ||
| Extratemporal white matter abnormalities in mesial temporal lobe epilepsy demonstrated with diffusion tensor imaging. | Q31056028 | ||
| Voxel-based morphometry of temporal lobe epilepsy: an introduction and review of the literature | Q31142114 | ||
| Diffusion tensor analysis of temporal and extra-temporal lobe tracts in temporal lobe epilepsy. | Q31153616 | ||
| ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes | Q33252737 | ||
| In vivo diffusion tensor imaging and histopathology of the fimbria-fornix in temporal lobe epilepsy | Q33525443 | ||
| The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study | Q34224445 | ||
| Normal magnetic resonance imaging and medial temporal lobe epilepsy: the clinical syndrome of paradoxical temporal lobe epilepsy. | Q34558095 | ||
| The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission | Q34683964 | ||
| Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies | Q35011242 | ||
| Medial temporal lobe atrophy in patients with refractory temporal lobe epilepsy. | Q35560316 | ||
| A new clinico-pathological classification system for mesial temporal sclerosis | Q35630377 | ||
| Patterns of treatment response in newly diagnosed epilepsy. | Q35948540 | ||
| Significance of mesial temporal atrophy in relation to intracranial ictal and interictal stereo EEG abnormalities | Q48953917 | ||
| Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy | Q49068872 | ||
| Absolute spike frequency predicts surgical outcome in TLE with unilateral hippocampal atrophy | Q49104811 | ||
| MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. | Q53616448 | ||
| Prognostic factors in patients with mesial temporal lobe epilepsy | Q56991679 | ||
| Whole-brain voxel-based statistical analysis of gray matter and white matter in temporal lobe epilepsy | Q57042069 | ||
| Antiepileptic drug response in temporal lobe epilepsy: A clinical and MRI morphometry study | Q57086538 | ||
| Structural Abnormalities are Similar in Familial and Nonfamilial Mesial Temporal Lobe Epilepsy | Q57086600 | ||
| Voxel-Based Morphometry Reveals Gray Matter Network Atrophy in Refractory Medial Temporal Lobe Epilepsy | Q57086604 | ||
| Familial mesial temporal lobe epilepsy: a benign epilepsy syndrome showing complex inheritance | Q57808240 | ||
| Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1 | Q57840857 | ||
| Glia as a source of cytokines: implications for neuronal excitability and survival | Q37069529 | ||
| Voxel-based optimized morphometry (VBM) of gray and white matter in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis | Q37348445 | ||
| Bilateral Hippocampal Atrophy in Medial Temporal Lobe Epilepsy | Q39472441 | ||
| Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy | Q39893640 | ||
| Clinical challenges in invasive monitoring in epilepsy surgery | Q40912273 | ||
| Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis | Q42526811 | ||
| Mesial temporal sclerosis is linked with more widespread white matter changes in temporal lobe epilepsy | Q42577404 | ||
| Long-term epilepsy surgery outcomes in patients with MRI-negative temporal lobe epilepsy | Q42774503 | ||
| The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET. | Q43102896 | ||
| Dynamic changes in white and gray matter volume are associated with outcome of surgical treatment in temporal lobe epilepsy | Q43291469 | ||
| Seizure outcome after anterior temporal lobectomy and its predictors in patients with apparent temporal lobe epilepsy and normal MRI. | Q43605019 | ||
| Benign mesial temporal lobe epilepsy | Q44054641 | ||
| Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy | Q44295945 | ||
| Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia. | Q44393948 | ||
| From mesial temporal lobe to temporoperisylvian seizures: a quantified study of temporal lobe seizure networks | Q45106912 | ||
| Altered spontaneous neuronal activity of the default-mode network in mesial temporal lobe epilepsy. | Q45904251 | ||
| Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis | Q46542069 | ||
| White-matter diffusion abnormalities in temporal-lobe epilepsy with and without mesial temporal sclerosis. | Q47259598 | ||
| Clinical and neuroimaging features of good and poor seizure control patients with mesial temporal lobe epilepsy and hippocampal atrophy | Q47856061 | ||
| A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories | Q47906345 | ||
| Surgical outcome in patients with epilepsy and dual pathology | Q48194745 | ||
| Persistent seizures following left temporal lobe surgery are associated with posterior and bilateral structural and functional brain abnormalities | Q48215445 | ||
| Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. | Q48232709 | ||
| Outcome of surgical treatment in familial mesial temporal lobe epilepsy | Q48240881 | ||
| Temporal lobe epilepsy and hippocampal sclerosis: lessons from depth EEG recordings | Q48253168 | ||
| Does resection of the medial temporal lobe improve the outcome of temporal lobe epilepsy surgery? | Q48259286 | ||
| Thalamic changes in temporal lobe epilepsy with and without hippocampal sclerosis: a diffusion tensor imaging study. | Q48263940 | ||
| MRI and EEG as long-term seizure outcome predictors in familial mesial temporal lobe epilepsy | Q48272922 | ||
| MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy | Q48310804 | ||
| Is the underlying cause of epilepsy a major prognostic factor for recurrence? | Q48349482 | ||
| Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region | Q48404732 | ||
| The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy | Q48426120 | ||
| Magnetic resonance imaging evidence of hippocampal sclerosis in asymptomatic, first-degree relatives of patients with familial mesial temporal lobe epilepsy | Q48430726 | ||
| Diffusion tensor MRI in temporal lobe epilepsy. | Q48455363 | ||
| Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy | Q48459567 | ||
| Hippocampal abnormalities and seizure recurrence after antiepileptic drug withdrawal. | Q48475024 | ||
| Temporopolar changes in temporal lobe epilepsy: a quantitative MRI-based study. | Q48481264 | ||
| Predictors of outcome after temporal lobectomy for the treatment of intractable epilepsy | Q48487009 | ||
| Preeminence of extrahippocampal structures in the generation of mesial temporal seizures: evidence from human depth electrode recordings | Q48558170 | ||
| Perfusion patterns during temporal lobe seizures: relationship to surgical outcome. | Q48587117 | ||
| MRI evidence of mesial temporal sclerosis in sporadic "benign" temporal lobe epilepsy. | Q48634773 | ||
| Intracranial EEG substrates of scalp ictal patterns from temporal lobe foci | Q48697321 | ||
| The spectrum of hippocampal sclerosis: a quantitative magnetic resonance imaging study | Q48820826 | ||
| Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study | Q48902892 | ||
| P433 | issue | 12 | |
| P921 | main subject | temporal lobe epilepsy | Q616667 |
| P304 | page(s) | 1383-1394 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Understanding the spectrum of temporal lobe epilepsy: contributions for the development of individualized therapies | |
| P478 | volume | 13 |
| Q38211467 | Epilepsies associated with hippocampal sclerosis |
| Q47721183 | Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research? |
| Q53390056 | Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion. |
| Q39277824 | Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy |
Search more.